{"disease":{"id":"dementia","name":"Dementia","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":65},"drugs":{"marketed":[{"drug_id":"donepezil","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aricept","generic_name":"DONEPEZIL","company_name":"Eisai","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Cholinesterase Inhibitor","quality_score":75,"revenue":"800","mechanism":"Aricept works by blocking the enzyme that breaks down a key neurotransmitter in the brain, acetylcholine."},{"drug_id":"galantamine","indication_name":"Mild to moderate dementia of the Alzheimer's type","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Razadyne","generic_name":"GALANTAMINE","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"Acetylcholinesterase","drug_class":"Cholinesterase Inhibitor","quality_score":62,"revenue":null,"mechanism":"Razadyne works by blocking the enzyme that breaks down acetylcholine, allowing more of this neurotransmitter to be available in the brain."},{"drug_id":"galantamine-hydrobromide","indication_name":"Mild to moderate dementia of the Alzheimer's type","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"GALANTAMINE HYDROBROMIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":31,"revenue":null,"mechanism":null},{"drug_id":"dihydroergocornine","indication_name":"Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"9,10-Dihydroergocornine","generic_name":"dihydroergocornine","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"dihydroergocornine","quality_score":13,"revenue":null,"mechanism":""},{"drug_id":"benzgalantamine","indication_name":"mild to moderate dementia of the Alzheimer's type","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zunveyl","generic_name":"BENZGALANTAMINE","company_name":"Alpha Cognition","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":56,"revenue":null,"mechanism":"Zunveyl works by enhancing communication between brain cells, specifically by stimulating cholinergic receptors."},{"drug_id":"pramiracetam","indication_name":"Senile dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Amacetam","generic_name":"PRAMIRACETAM","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"pramiracetam","quality_score":null,"revenue":null,"mechanism":"Pramiracetam works by increasing the activity of certain neurotransmitters in the brain, such as acetylcholine, to enhance memory and cognitive function."},{"drug_id":"donepezil-aricept","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Donepezil (Aricept)","company_name":"University of Virginia","drug_phase":"marketed","molecular_target":"Beta-secretase 1, Multidrug resistance protein 1, Acetylcholine receptor subunit epsilon","drug_class":"Acetylcholinesterase Inhibitor","quality_score":26,"revenue":null,"mechanism":""},{"drug_id":"exelon","indication_name":"Dementia associated with Parkinson's Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Exelon","company_name":"US Department of Veterans Affairs","drug_phase":"marketed","molecular_target":"Acetylcholinesterase, Cholinesterase, Acetylcholine receptor subunit epsilon","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"rivastigmine","indication_name":"Dementia associated with Parkinson's Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Exelon","generic_name":"rivastigmine","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Acetylcholinesterase, Cholinesterase, Acetylcholine receptor subunit epsilon","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"aricept","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Aricept","company_name":"Eisai Korea Inc.","drug_phase":"marketed","molecular_target":"Beta-secretase 1, Multidrug resistance protein 1, Acetylcholine receptor subunit epsilon","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"namenda","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Namenda","company_name":"Inova Health Care Services","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1, 5-hydroxytryptamine receptor 3A, Acetylcholinesterase","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"acetylcarnitine","indication_name":"Senile dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Levocarnitine Acetyl","generic_name":"ACETYLCARNITINE","company_name":"","drug_phase":"discontinued","molecular_target":"","drug_class":"Carnitine Analog","quality_score":null,"revenue":null,"mechanism":"Acetylcarnitine works by supporting the transport of fatty acids into mitochondria, where they can be used for energy production."},{"drug_id":"epicriptine","indication_name":"Senile dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Beta-Dihydroergocryptine","generic_name":"EPICRIPTINE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"epicriptine","quality_score":13,"revenue":null,"mechanism":""},{"drug_id":"memantine","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Namenda","generic_name":"MEMANTINE","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Glutamate NMDA receptor; GRIN1/GRIN2A","drug_class":"N-methyl-D-aspartate Receptor Antagonist","quality_score":60,"revenue":null,"mechanism":"Namenda works by blocking the action of glutamate at the NMDA receptor, reducing excessive neural activity associated with Alzheimer's disease."},{"drug_id":"ebixa","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ebixa","company_name":"Konkuk University Medical Center","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1, 5-hydroxytryptamine receptor 3A, Acetylcholinesterase","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"ioflupane","indication_name":"suspected dementia with Lewy bodies","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ioflupane I 123","generic_name":"IOFLUPANE","company_name":"Ge Hlthcare Inc","drug_phase":"marketed","molecular_target":"Dopamine transporter (DaT)","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":70,"revenue":null,"mechanism":"Ioflupane I-123 binds to the dopamine transporter (DaT) in the striatum, allowing visualization of brain striata through SPECT imaging."},{"drug_id":"donepezil-hydrochloride","indication_name":"Dementia of the Alzheimer's type","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"DONEPEZIL HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":28,"revenue":null,"mechanism":null},{"drug_id":"ergoloid-mesylates","indication_name":"Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydergine","generic_name":"ERGOLOID MESYLATES","company_name":"Novartis","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":20,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":18,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06095284","title":"Prescribing Trends and Associated Outcomes of Antiepileptic Drugs in US Nursing Homes Surrounding the COVID-19 Pandemic","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":22500000,"lead_sponsor_name":"Virginia Commonwealth University","has_results":false},{"nct_id":"NCT04321486","title":"Natural History and Patient Journey in Dementia: a Nationwide Linked Electronic Health Records Study of 5.6 Million Individuals.","phase":"","overall_status":"UNKNOWN","enrollment_count":4309481,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT05796037","title":"An Observational Study of Patients Living With Chronic Neurological Diseases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1500000,"lead_sponsor_name":"Target PharmaSolutions, Inc.","has_results":false},{"nct_id":"NCT07205978","title":"Nut Consumption and Prevention of Non-communicable Diseases: A Global Individual Participant Data Meta-analysis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1000000,"lead_sponsor_name":"Institut Investigacio Sanitaria Pere Virgili","has_results":false},{"nct_id":"NCT05813652","title":"Relative Impacts on Preventative Primary Care--a Longitudinal Evaluation of COVID-19:Phase 1","phase":"","overall_status":"COMPLETED","enrollment_count":919928,"lead_sponsor_name":"McMaster University","has_results":false},{"nct_id":"NCT06440447","title":"EXploring Patterns of Use and Effects of Adult Day Programs to Improve Trajectories of Continuing CarE","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500000,"lead_sponsor_name":"York University","has_results":false},{"nct_id":"NCT03943641","title":"Dementia Risk Prediction Model: Development and Validation","phase":"","overall_status":"COMPLETED","enrollment_count":400000,"lead_sponsor_name":"University of Edinburgh","has_results":false},{"nct_id":"NCT05371782","title":"Mortality Risk Prediction Tool in Hospitalized Dementia Patients","phase":"","overall_status":"COMPLETED","enrollment_count":298576,"lead_sponsor_name":"University of Toronto","has_results":false},{"nct_id":"NCT03631069","title":"Detecting Dementia in the Retina Using Optical Coherence Tomography","phase":"","overall_status":"UNKNOWN","enrollment_count":280000,"lead_sponsor_name":"Moorfields Eye Hospital NHS Foundation Trust","has_results":false},{"nct_id":"NCT06266325","title":"Development and Validation of a Dementia Life Expectancy Tool","phase":"","overall_status":"COMPLETED","enrollment_count":202217,"lead_sponsor_name":"University of Toronto","has_results":false},{"nct_id":"NCT07093684","title":"Dementia and Kidney Disease: Epidemiological Approaches to Risk Factors and Treatment Strategies","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200000,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT03987633","title":"EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality","phase":"","overall_status":"RECRUITING","enrollment_count":200000,"lead_sponsor_name":"Future Genetics Limited","has_results":false},{"nct_id":"NCT03638583","title":"Alzheimer Prevention Trials (APT) Webstudy","phase":"","overall_status":"RECRUITING","enrollment_count":200000,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT02612688","title":"Pragmatic Trial of Video Education in Nursing Homes","phase":"NA","overall_status":"COMPLETED","enrollment_count":197692,"lead_sponsor_name":"Brown University","has_results":true},{"nct_id":"NCT06090578","title":"TabCAT Brain Health Assessment in Primary Care","phase":"NA","overall_status":"RECRUITING","enrollment_count":180000,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT05817188","title":"Medication Repurposing to Stop Cognitive Decline in Dementia","phase":"","overall_status":"COMPLETED","enrollment_count":100000,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT04701177","title":"Digitally-enhanced, Decentralized, Multi-omics Observational Cohort","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100000,"lead_sponsor_name":"Greece 2021 Committee","has_results":false},{"nct_id":"NCT03653156","title":"China Cognition and Aging Study","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Capital Medical University","has_results":false},{"nct_id":"NCT05315895","title":"The Dampness Syndrome of Chinese Medicine Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Guangzhou University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT06877182","title":"Novel Neuroradiological Workflow for the Assisted DIAgnosis and Management of DEMentia with Artificial Intelligence","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":80000,"lead_sponsor_name":"IRCCS SYNLAB SDN","has_results":false},{"nct_id":"NCT07399288","title":"Postherpetic Neuralgia After Herpes Zoster and Incident Dementia Risk","phase":"","overall_status":"COMPLETED","enrollment_count":68786,"lead_sponsor_name":"China Medical University Hospital","has_results":false},{"nct_id":"NCT04819191","title":"Improving Communication for Primary Care Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":64915,"lead_sponsor_name":"Johns Hopkins University","has_results":true},{"nct_id":"NCT06209515","title":"Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":61292,"lead_sponsor_name":"Kuopio University Hospital","has_results":false},{"nct_id":"NCT03621839","title":"New CSF Biomarkers for Alzheimer's Disease","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT06641726","title":"Creating a Global Research Database That Connects Genetic Information and Long-term Health Data to Improve Personalized Treatment for People With Serious Mental Illness","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Akrivia Health","has_results":false},{"nct_id":"NCT03323502","title":"Aligning Patient Preferences: a Role Offering Alzheimer's Patients, Caregivers, and Healthcare Providers Education and Support","phase":"NA","overall_status":"COMPLETED","enrollment_count":47396,"lead_sponsor_name":"Indiana University","has_results":true},{"nct_id":"NCT05607732","title":"Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":45257,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT03934957","title":"Hamburg City Health Study - a German Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":45000,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT06033066","title":"Financial Incentives and Recruitment to the APT Webstudy","phase":"NA","overall_status":"COMPLETED","enrollment_count":44844,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT04175977","title":"The Hospice Advanced Dementia Symptom Management and Quality of Life Trial (HAS-QOL)","phase":"NA","overall_status":"COMPLETED","enrollment_count":44143,"lead_sponsor_name":"NYU Langone Health","has_results":false},{"nct_id":"NCT04571697","title":"A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":34647,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT05922319","title":"Effects of Training Dose on Computerized Cognitive Training in Patients With Cognitive Impairment","phase":"","overall_status":"COMPLETED","enrollment_count":21845,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT04262206","title":"Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT05023564","title":"PUMCH Dementia Longitudinal Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT06079203","title":"ED-LEAD: Emergency Departments Leading the Transformation of Alzheimer's and Dementia Care","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":19200,"lead_sponsor_name":"NYU Langone Health","has_results":false},{"nct_id":"NCT07224347","title":"Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":19114,"lead_sponsor_name":"Anne Murray","has_results":false},{"nct_id":"NCT03470584","title":"Vegetarian Diet and Chronic Degenerative Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":18064,"lead_sponsor_name":"Dalin Tzu Chi General Hospital","has_results":false},{"nct_id":"NCT04792086","title":"Disease Containment Measures Among Older Adults During the Covid-19 Pandemia","phase":"","overall_status":"UNKNOWN","enrollment_count":12000,"lead_sponsor_name":"Norwegian Centre for Ageing and Health","has_results":false},{"nct_id":"NCT02014246","title":"Genetic Characterization of Movement Disorders and Dementias","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"National Institute on Aging (NIA)","has_results":false},{"nct_id":"NCT04289389","title":"Prevalence and Level of Diagnosis of Dementia in a Population-based Sample in the County of Trøndelag","phase":"","overall_status":"COMPLETED","enrollment_count":11675,"lead_sponsor_name":"Norwegian Centre for Ageing and Health","has_results":false},{"nct_id":"NCT04857060","title":"Palliative Care Educator","phase":"NA","overall_status":"COMPLETED","enrollment_count":11174,"lead_sponsor_name":"Tufts Medical Center","has_results":true},{"nct_id":"NCT04786561","title":"Depression, Anxiety and Social Relationships as Risk Factors for Dementia","phase":"","overall_status":"COMPLETED","enrollment_count":11000,"lead_sponsor_name":"Norwegian Centre for Ageing and Health","has_results":false},{"nct_id":"NCT06650969","title":"China Diabetes Cognitive Dysfunction Early Diagnosis and Intervention Study (China-DECODE Study)","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","has_results":false},{"nct_id":"NCT06338215","title":"Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality","phase":"NA","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Clinica Universidad de Navarra, Universidad de Navarra","has_results":false},{"nct_id":"NCT05892952","title":"IONA Longitudinal Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Brain Health Scotland Life Sciences Ltd","has_results":false},{"nct_id":"NCT04114994","title":"Longitudinal Cognitive Assessment by BoCA","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Alzheimer's Light LLC","has_results":false},{"nct_id":"NCT04466722","title":"The A-LIST WMM Insights Series","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"UsAgainstAlzheimer's","has_results":false},{"nct_id":"NCT03672448","title":"The China Longitudinal Aging Study of Cognitive Impairment","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Shanghai Mental Health Center","has_results":false},{"nct_id":"NCT06203106","title":"NYSCF Scientific Discovery Biobank","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"New York Stem Cell Foundation Research Institute","has_results":false},{"nct_id":"NCT06719453","title":"Prevalence of Alzheimer's Disease Pathology in the Community","phase":"","overall_status":"COMPLETED","enrollment_count":9663,"lead_sponsor_name":"Helse Stavanger HF","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}